Exploring Clinical Characteristics and Treatment Outcomes of Squamous Cell Lung Cancers Harboring EGFR and ALK Mutations: A Case Series

被引：0
|
作者：
Chattopadhyay, P. [1 ]
Sureshkumar, K. [2 ]
Kareff, S. [1 ,3 ]
Rodriguez, E. [1 ,3 ]
机构：
[1] Univ Miami, Jackson Mem Hosp, Miami, FL 33136 USA
[2] Univ Miami, Miami, FL USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Squamous cell cancer of lung; EGFR; ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.12E.05
引用
收藏
页码：S654 / S654
页数：1
相关论文
共 50 条
  • [41] Precision Treatment of Advanced Lung Adenocarcinoma With Coexisting EGFR, ALK, and ROS1 Mutations: A Case Report
    Zhang, Yaping
    Wang, Hui
    Wang, Xiaoyan
    Li, Shuai
    Fang, Hongming
    CLINICAL LUNG CANCER, 2021, 22 (05) : E699 - E702
  • [42] Serum C-Reactive Protein Level Predicts Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Koyama, Nobuyuki
    Aoshiba, Kazutetsu
    Nakamura, Hiroyuki
    CANCER INVESTIGATION, 2020, 38 (02) : 122 - 129
  • [43] Diverse clinical outcomes for the EGFR-mutated and ALK-rearranged advanced non-squamous non-small cell lung cancer
    Lin, Chun-Wei
    Huang, Kuo-Yang
    Lin, Ching-Hsiung
    Hou, Ming-Hon
    Lin, Sheng-Hao
    ONCOLOGY LETTERS, 2025, 29 (03)
  • [44] Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naive Patients with Advanced Lung Adenocarcinoma
    Park, Jangchul
    Kobayashi, Yoshihisa
    Urayama, Kevin Y.
    Yamaura, Hidekazu
    Yatabe, Yasushi
    Hida, Toyoaki
    PLOS ONE, 2016, 11 (08):
  • [45] Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements
    Wu, Shafei
    Wang, Jinghui
    Zhou, Lijuan
    Su, Dan
    Liu, Yuanyuan
    Liang, Xiaolong
    Zhang, Shucai
    Zeng, Xuan
    THORACIC CANCER, 2015, 6 (04) : 413 - 420
  • [46] Clinical efficacy of EGFR-TKIs in combination with chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations
    Zhang, Minghui
    Liu, Mingyang
    Wang, Yan
    JOURNAL OF THORACIC DISEASE, 2016, 8 (10) : E1293 - E1295
  • [47] Clinical characteristics and PD-L1 expression in primary lung squamous cell carcinoma: A case series
    Fernandez-Trujillo, Liliana
    Garcia-Robledo, Juan E.
    Zuniga-Restrepo, Valeria
    Sua, Luz F.
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 30
  • [48] Clinical Characteristics and Outcome of Patients with Non-Small Cell Lung Cancer Harboring BRAF Mutations
    Zhang, M.
    Wang, H.
    Ma, Z.
    Zhang, X.
    Li, P.
    Yan, X.
    Zhang, G.
    Niu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S695 - S695
  • [49] Clinical Characteristics and Outcomes of Patients with Primary Lung Adenocarcinoma Harboring ALK Rearrangements Detected by FISH, IHC, and RT-PCR
    Wang, Jinghui
    Cai, Yiran
    Dong, Yujie
    Nong, Jingying
    Zhou, Lijuan
    Liu, Guimei
    Su, Dan
    Li, Xi
    Wu, Shafei
    Chen, Xuejing
    Qin, Na
    Zeng, Xuan
    Zhang, Haiqing
    Zhang, Zongde
    Zhang, Shucai
    PLOS ONE, 2014, 9 (07):
  • [50] EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
    Leal, Jose Luis
    Alexander, Marliese
    Itchins, Malinda
    Wright, Gavin M.
    Kao, Steven
    Hughes, Brett G. M.
    Pavlakis, Nick
    Clarke, Stephen
    Gill, Anthony J.
    Ainsworth, Hannah
    Solomon, Benjamin
    John, Thomas
    CLINICAL LUNG CANCER, 2021, 22 (06) : E859 - E869
12345